Back to Search Start Over

Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions.

Authors :
Egan, Brent M.
Kjeldsen, Sverre E.
Narkiewicz, Krzysztof
Kreutz, Reinhold
Burnier, Michel
Source :
Blood Pressure. Dec2022, Vol. 31 Issue 1, p164-168. 5p.
Publication Year :
2022

Abstract

One relatively simple and potentially scalable approach to improving hypertension control is greater use of single-pill combinations (SPC) containing two or more different classes of antihypertensive medications as initial and add-in therapy [[4], [6], [8], [10], [12]]. 5 ComboRx: combination treatment with two anti-hypertensive medication either as a single-pill or separate pill; SPC: single-pill combination antihypertensive therapy; FEC: free equivalent combination single antihypertensive medication, two antihypertensive medications as two separate pills with same medications comparator SPC. SPC accounted for 6.3% of antihypertensive medication prescriptions and 12.3% of antihypertensive medications within the top 300 (Table 3) [[21]]. Thus, it often takes two years or more of uncontrolled hypertension before antihypertensive medication is added or the dose increased for an existing medication. [Extracted from the article]

Details

Language :
English
ISSN :
08037051
Volume :
31
Issue :
1
Database :
Academic Search Index
Journal :
Blood Pressure
Publication Type :
Academic Journal
Accession number :
160300914
Full Text :
https://doi.org/10.1080/08037051.2022.2095254